The acquisition of a Holmium Laser, purchased with charitable funds, ensures Kingston Hospital is at the forefront of providing the best possible surgical interventions for a range of conditions including enlarged prostate glands, kidney stones and bladder cancer.
Surgery is normally required for men with enlarged prostate glands who have not responded satisfactorily to medicine or have more severe problems. The Holmium Laser provides significant advantages over transurethral resection of the prostate, which is the most common surgical intervention currently. As well as reducing the incidence of post-operative bleeding, patients achieve a speedier recovery, reducing the time spent in hospital. The chance of needing further surgery is also much lower at 2% compared with 15% to 20% for patients who undergo transurethral resection.